Cochlear innovate and produce implantable hearing solutions. The Company operates through three segments, based on geographical basis: America, EMEA and Asia Pacific. America includes the United States, Canada and Latin America. EMEA includes Europe, Middle East and Africa. Asia Pacific includes Australasia and Asia. The Company's products and solutions include Nucleus® Cochlear Implants, Carina middle ear implants, Baha bone conduction implants, Vistafix® Bone Anchored Prosthetics, and Cochlear™ True Wireless™ Devices. Cochlear was founded in 1981, it is headquartered in Sydney, Australia.